Syntec Optics (OPTX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting will be held virtually on December 20, 2024, to elect two directors, ratify the appointment of Marcum LLP as auditor, approve RSU grants under the 2023 Equity Incentive Plan, and address other business.
Shareholders of record as of November 7, 2024, are entitled to vote, with each share carrying one vote; a majority of shares constitutes a quorum.
Proxy materials and the annual report are available online, and shareholders are encouraged to vote in advance via internet, phone, or mail.
Voting matters and shareholder proposals
Proposals include electing two directors until 2027, ratifying Marcum LLP as auditor for 2024, approving RSU grants, and considering other business.
Directors are elected by plurality; auditor ratification and RSU approval require a majority of votes cast.
Broker non-votes may affect non-routine items; shareholders are urged to provide voting instructions to brokers.
Shareholder proposals for the 2025 meeting must be received by July 11, 2025, for inclusion in proxy materials.
Board of directors and corporate governance
The board consists of three staggered classes, totaling five directors, with two up for election in 2024.
Nominees Brent Rosenthal and Dean Rudy bring expertise in finance, operations, and industry leadership.
Board committees include audit, compensation, and nominating/governance, all compliant with SEC and Nasdaq rules.
The board is responsible for risk oversight, while management handles day-to-day risk management.
Independent directors are determined per Nasdaq standards; the company relies on a controlled company exemption for board independence.
Latest events from Syntec Optics
- Strong H1 2025 profit growth and margin expansion driven by defense, biomedical, and communications.OPTX
Q2 202513 Feb 2026 - Gross margin rose to 29% in H1 2025 as sales and adjusted EBITDA improved year-over-year.OPTX
Q4 202413 Feb 2026 - Q1 2025 net income turned positive on 13% sales growth and improved margins.OPTX
Q1 202513 Feb 2026 - Q3 2025 revenue rose sequentially but margins fell; liquidity improved and Q4 outlook is positive.OPTX
Q3 202512 Feb 2026 - Q2 sales up 12% sequentially, product growth strong, and Q3 outlook robust.OPTX
Q2 20242 Feb 2026 - Q3 sales up 19% year-over-year, but higher costs led to a net loss; Q4 outlook is positive.OPTX
Q3 202413 Jan 2026 - Virtual meeting to vote on directors, auditor, RSUs, and governance amendments; board recommends approval.OPTX
Proxy Filing8 Dec 2025 - Shareholders will vote on directors, auditor ratification, RSU grants, and governance amendments.OPTX
Proxy Filing29 Nov 2025